Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
ID: 358021Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358021

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DC-25-003.html
Timeline
    Description

    The National Institutes of Health (NIH) is soliciting applications for a Cooperative Agreement aimed at advancing in vivo high-resolution imaging technologies for inner ear visualization, specifically through the funding opportunity RFA-DC-25-003. This initiative seeks to support high-risk clinical trials that enhance imaging resolution or develop new techniques to visualize inner ear structures in detail, which is crucial for improving diagnostics and treatment of hearing and balance disorders. The program emphasizes the need for advanced imaging technologies to bridge gaps in understanding inner ear pathologies, with a funding ceiling of $500,000 annually over a maximum of five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by October 1, 2026.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-DC-25-003-Full-Announcement.html
    RFA-DC-25-003.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting applications for a Cooperative Agreement aimed at advancing in vivo high-resolution imaging technologies for inner ear visualization. The funding opportunity (RFA-DC-25-003) supports high-risk clinical trials that enhance imaging resolution or develop new imaging techniques to visualize inner ear structures in detail for improved diagnostics and treatment of hearing and balance disorders. Proposed projects should focus on technology that requires FDA oversight, aimed at establishing efficacy in high-risk scenarios. The initiative encourages a multidisciplinary approach, necessitating close collaboration with NIH for oversight and guidance during trials that involve human studies. Applications should clearly demonstrate how improved imaging capabilities can lead to better diagnostic outcomes and therapeutic interventions, particularly for conditions like Ménière’s disease or vestibular disorders. Funding, capped at $500,000 annually over a maximum of five years, targets eligible organizations, including academic institutions and nonprofits. The call underlines the pressing need for advanced imaging technologies to bridge gaps in understanding inner ear pathologies, promoting significant advancements in clinical practice.
    Similar Opportunities
    Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through a cooperative agreement aimed at advancing in vivo high-resolution imaging technologies for inner ear visualization, specifically under the announcement RFA-DC-24-005. This initiative seeks to support high-risk clinical trials that enhance existing imaging techniques or develop new technologies capable of visualizing inner ear structures with significantly greater detail and accuracy in awake patients. The program emphasizes the importance of multidisciplinary collaboration and is particularly focused on projects that may require FDA oversight or involve higher participant risks, with a total funding amount of $2 million available for 2-4 awards, each with a maximum budget of $500,000 per year for up to five years. Interested applicants must submit their proposals by January 1, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)" aimed at advancing imaging technologies for the inner ear. This initiative seeks to support the development of innovative in vivo imaging techniques that can visualize the inner ear's structures with enhanced detail and accuracy, thereby improving the diagnosis and treatment of auditory and vestibular disorders. The program encourages a multidisciplinary approach and supports low-risk clinical trials, with an estimated total funding of $500,000 available for 4-6 awards in FY 2025. Applications are due by May 3, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "In Vivo High-Resolution Imaging for Inner Ear Visualization," aimed at advancing imaging technologies for the non-invasive visualization of the inner ear in living patients. This initiative seeks to support the development of both new and improved imaging techniques that can provide detailed insights into inner ear structures, such as hair cells and membranes, with a focus on applications that can be utilized in awake patients. The program is particularly significant for enhancing the diagnosis and treatment of inner ear disorders, reflecting NIH's commitment to innovative health research. A total of $2 million is allocated for 2-4 awards in fiscal year 2024, with applications opening on January 1, 2024, and a closing date for submissions set for June 3, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems" under the cooperative agreement mechanism (UG3/UH3), aimed at advancing optical imaging technologies to address the challenges of light scattering in biological tissues. This initiative seeks to develop next-generation non-invasive or minimally-invasive optical imaging techniques that enhance penetration depth and resolution, thereby improving diagnostic and research capabilities in biomedical fields. With a total funding commitment of approximately $4.9 million available over a maximum project period of three years, eligible applicants include higher education institutions, non-profits, and small businesses, all of which must submit their proposals electronically through Grants.gov by February 7, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Deafness and Other Communication Disorders (NIDCD) for cooperative agreements aimed at supporting clinical trials in communication disorders. Applicants are required to propose a single clinical trial that may necessitate FDA oversight, demonstrate efficacy, or involve higher risks, with an emphasis on substantial interaction with NIDCD staff and comprehensive protections for human subjects. This initiative is crucial for advancing research and establishing effective treatments for conditions related to hearing, balance, taste, smell, voice, speech, and language. Interested applicants can access further details and guidelines through the announcement available at NIH Grants, with a budget that may exceed $700,000 in specific circumstances and a closing date for applications set for October 18, 2027.
    NIDCD's Mentored Research Education Pathway for Otolaryngology Residents and Medical Students (R25 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the NIDCD's Mentored Research Education Pathway for Otolaryngology Residents and Medical Students (R25), aimed at enhancing recruitment into research careers within the biomedical field. This program supports educational activities that provide mentorship and research opportunities for medical students and resident-investigators, addressing the shortage of clinician-investigators in otolaryngology. Eligible applicants include higher education institutions and nonprofits, with a focus on fostering diversity among participants, and funding is capped at $499,999 in direct costs per year for a duration of 12 to 24 months. Interested parties can find more information and apply by contacting NIH Grants Information at grantsinfo@nih.gov, with applications due by September 29, 2026.
    NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering research grants aimed at translating basic research findings into clinical practice, specifically for communication disorders. This funding opportunity encourages collaborations between basic scientists and clinicians to develop practical applications that address hearing, balance, smell, taste, voice, and language disorders, with a focus on milestone-driven proposals that demonstrate a clear connection to clinical conditions and impactful outcomes. The grants, limited to a maximum of $500,000 in direct costs annually, are expected to support 2-3 awards in FY25, with applications due by October 12, 2027. Interested applicants can find more information and submit their proposals through Grants.gov, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDCD Early Career Research (ECR) Award (R21 Clinical Trial Optional) to support novice researchers in establishing independent careers in biomedical and behavioral sciences, specifically in areas related to hearing, balance, smell, taste, voice, speech, or language. This grant mechanism allows for various research projects, including secondary data analysis and translational research, but cannot be utilized for thesis or dissertation work. The award aims to generate preliminary data to support future R01 applications, with a total funding of up to $375,000 over three years, and applications are due beginning January 19, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-120.html.
    NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDCD Early Career Research (ECR) Award (R21 Clinical Trial Optional) to support emerging researchers in establishing independent careers in biomedical and behavioral research related to hearing, balance, smell, taste, voice, speech, or language. This grant allows for various project types, including secondary data analysis, small research initiatives, and the development of research methodologies or technologies, with the goal of generating preliminary data for future R01 applications. Eligible applicants include a diverse range of institutions, particularly those serving underrepresented groups, and may request up to $375,000 in direct costs over a three-year period. Applications are due by February 17, 2027, and interested parties can find more information and submission guidelines at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering a funding opportunity titled "NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)." This initiative aims to support cooperative agreements for clinical trials that require FDA oversight, are intended to establish efficacy, or present higher risks to participants, with a budget exceeding $700,000. The funding is crucial for advancing clinical practices in treating communication disorders, emphasizing the inclusion of diverse populations in recruitment and retention strategies. Interested applicants, including various educational and nonprofit organizations, must submit their applications by January 27, 2024, and can find more information at NIH Grants.